Developer docs
API playgroundTry for free, no card

Search company profiles

Titan Biotech

Full company profile

uuid003gm2n

Namestring
Titan Biotech
Legal namestring
Titan Biotech Ltd.
Company typeenum
Public
Founded yearint
1992
Descriptiontext

Titan Biotech Limited is a Delhi-headquartered, BSE-listed manufacturer and exporter of biological and specialty chemical products serving nutraceutical, biopharmaceutical, animal nutrition, and food industry customers in more than 100 countries. The company operates manufacturing facilities in Bhiwadi and Chopanki (Rajasthan) with 501–1,000 employees, and produces a portfolio that spans collagen peptides, protein hydrolysates, yeast extracts, peptones, and calcium propionate, alongside proprietary branded lines such as OXIBIL, Titagen, and Unstergen. Its subsidiary Peptech Biosciences extends the biological products platform with additional manufacturing and sales capability, while dedicated logistics and overseas marketing subsidiaries support the export-heavy go-to-market model.

The company's revenue mechanics are predominantly B2B ingredient and biological-product supply, sold both as bulk inputs and as branded finished formulations to international buyers, with go-to-market executed through continuous participation at major industry trade platforms (CPHI, Vitafoods, EUROTIER, Fi Asia). Pricing reflects a mix of specialty/regulated inputs (carrying higher unit economics) and commodity-adjacent categories, with quality and compliance certifications — ISO 13485:2016, ISO 9001:2015, GMP, GMP+, FSSC 22000, FSSAI, and HALAL — functioning as the primary qualification and pricing lever for regulated end-markets. The export-led, multi-vertical structure is reflected in the financials: Q3 FY26 revenue of ₹56.51 crores (up 47.62% YoY) and PAT up 94.31% YoY, with a market capitalization of ₹1,685.79 crores, a P/E of 59.70, and a near-debt-free balance sheet (D/E 0.04) following a 1:5 stock split executed in February 2026.

Short descriptiontext

Titan Biotech is a Delhi-headquartered, BSE-listed manufacturer and exporter of biological and specialty chemical products — including collagen peptides, yeast extracts, and peptones — serving nutraceutical, biopharmaceutical, animal nutrition, and food customers across 100+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersDelhi, India
HQ citystring
Delhi
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biological ingredients manufacturing, collagen peptides supplier, yeast extract production, protein hydrolysates manufacturer, biochemical export India
Industry5 codes
1Protein Hydrolysates & Peptides (Enzymatic Hydrolysates, Bioactive Peptides)
CodeAFAJAHAIPrimaryYes
2Animal-Derived Protein Ingredients (Egg, Collagen/Gelatin, Blood/Plasma Proteins)
CodeAFAJAHABPrimaryNo
3Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
CodeAFAJAKAGPrimaryNo
4Gelatin & Animal-Derived Hydrocolloids (Gelatin, Collagen, Isinglass)
CodeAFAJAMAGPrimaryNo
5Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids)
CodeCRADAOAJPrimaryNo
NAICS code3 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Food Manufacturing311
  • Animal Food Manufacturing3111
SIC code3 codes
  • Food And Kindred Products2000
  • Chemicals & Allied Products2800
  • Biological Products, (No Disgnostic Substances)2836
Product category
Biological Ingredients Manufacturing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1B2B Biological Ingredients Manufacturing
TypeOne Time License
Description

Manufacture and export of raw material ingredients for nutraceuticals, pharmaceuticals, cosmeceuticals, and food & beverage industries. Products include collagen peptides, protein hydrolysates, yeast extract, peptone, and specialty ingredients sold in bulk to manufacturers worldwide.

titanbiotechltd.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1OXIBIL
Description

Ox Bile Extract Powder brand for digestive health supplements in humans and animals

titanbiotechltd.com
+7 more records
Core offering1 text field

Titan Biotech manufactures and exports biological and biochemical products including collagen peptides, protein hydrolysates, yeast extract, peptone, and calcium propionate. These specialty ingredients are supplied in bulk to manufacturers in the pharmaceutical, nutraceutical, cosmeceutical, food & beverage, and animal nutrition industries across more than 100 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 47.62% YoY revenue growth to ₹56.51 crore in Q3 FY26
+2 more records
Product overview1 text field

Titan Biotech Limited is a manufacturer and exporter of biological products serving the pharmaceutical, nutraceuticals, food, and animal nutrition industries. The company's product portfolio centers on protein-based ingredients including collagen peptides (bovine, fish, and chicken-derived), various protein supplements (whey, milk, pea, brown rice, soy), and specialty ingredients like yeast extract, peptone, and protein hydrolysates. Their offerings span branded finished products (OXIBIL® ox bile extract, Titagen® fish collagen, Unstergen® chicken collagen) and bulk raw material ingredients. The company also produces animal nutrition additives including calcium propionate, active dry yeast, mannan oligosaccharides, chelated minerals, and butyrate salts. Supporting the pharmaceutical and nutraceutical segments are products like chondroitin sulfate, hyaluronic acid, L-glutathione, and cow colostrum powder. Manufacturing facilities are GMP and ISO certified, with products distributed across 100+ countries worldwide.

Product and service1 record
1Collagen Peptides
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Glanbia produces whey protein, milk protein, and other dairy-derived functional ingredients for sports nutrition and food — comparable to Titan's whey, milk protein, and protein hydrolysate lines sold into nutraceutical customers.

TypeDirect peer
Description

Rousselot, owned by Darling Ingredients, produces gelatin, collagen peptides, and peptone for pharma, food, and nutrition — a near-perfect comparable on Titan's core collagen and peptone lines, though at significantly larger scale.

TypeDirect peer
Description

Ohly, part of Associated British Foods, produces yeast extracts, savory flavor bases, and nutritional ingredients for food and fermentation — a direct comparable on Titan's yeast extract powder product line.

TypeDirect peer
Description

Gelita is the world's leading manufacturer of collagen peptides and gelatin for food, nutraceutical, and pharma applications — directly comparable to Titan's Titagen and Unstergen collagen offerings with overlapping customers and similar hydrolysis technology.

TypeBroad incumbent
Description

Symrise's Diana Pet Food division produces palatability enhancers, yeasts, and proteins for pet and animal nutrition — comparable to Titan's animal nutrition ingredients (yeast, MOS, calcium propionate) and peptone portfolio.

TypeBroad incumbent
Description

Kerry is a global taste and nutrition platform with food ingredients including yeast extracts, hydrolysates, and proteins — overlaps with Titan's yeast extract and HVP food ingredient lines but at much broader portfolio scale.

TypeDirect peer
Description

Armor Proteines manufactures protein hydrolysates, dairy proteins, and collagen peptides for nutrition, sports, and clinical applications — directly comparable to Titan's protein hydrolysate and collagen peptide lines.

TypeDirect peer
Description

Bioiberica produces chondroitin sulfate, hyaluronic acid, collagen, and other animal-derived bioactive ingredients for joint health and pharma — directly comparable to Titan's pharma/nutra ingredients portfolio including chondroitin and HA.

TypeDirect peer
Description

Through its PB Leiner division, Tessenderlo produces gelatin, collagen hydrolysates, and proteins for food and pharma — directly comparable to Titan's bovine/porcine collagen peptide range.

TypeDirect peer
Description

Weishardt is a European specialist in gelatin and collagen peptides for nutraceutical, cosmeceutical, and food applications, with comparable source-agnostic (fish/bovine/porcine) manufacturing capability to Titan's collagen business.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Titan Biotech

Biological Ingredients Manufacturingtitanbiotechltd.com

Titan Biotech is a Delhi-headquartered, BSE-listed manufacturer and exporter of biological and specialty chemical products — including collagen peptides, yeast extracts, and peptones — serving nutraceutical, biopharmaceutical, animal nutrition, and food customers across 100+ countries.

What Titan Biotech does

Titan Biotech Limited is a Delhi-headquartered, BSE-listed manufacturer and exporter of biological and specialty chemical products serving nutraceutical, biopharmaceutical, animal nutrition, and food industry customers in more than 100 countries. The company operates manufacturing facilities in Bhiwadi and Chopanki (Rajasthan) with 501–1,000 employees, and produces a portfolio that spans collagen peptides, protein hydrolysates, yeast extracts, peptones, and calcium propionate, alongside proprietary branded lines such as OXIBIL, Titagen, and Unstergen. Its subsidiary Peptech Biosciences extends the biological products platform with additional manufacturing and sales capability, while dedicated logistics and overseas marketing subsidiaries support the export-heavy go-to-market model.

The company's revenue mechanics are predominantly B2B ingredient and biological-product supply, sold both as bulk inputs and as branded finished formulations to international buyers, with go-to-market executed through continuous participation at major industry trade platforms (CPHI, Vitafoods, EUROTIER, Fi Asia). Pricing reflects a mix of specialty/regulated inputs (carrying higher unit economics) and commodity-adjacent categories, with quality and compliance certifications — ISO 13485:2016, ISO 9001:2015, GMP, GMP+, FSSC 22000, FSSAI, and HALAL — functioning as the primary qualification and pricing lever for regulated end-markets. The export-led, multi-vertical structure is reflected in the financials: Q3 FY26 revenue of ₹56.51 crores (up 47.62% YoY) and PAT up 94.31% YoY, with a market capitalization of ₹1,685.79 crores, a P/E of 59.70, and a near-debt-free balance sheet (D/E 0.04) following a 1:5 stock split executed in February 2026.

Titan Biotech firmographics

Firmographics
Name
Titan Biotech
Legal name
Titan Biotech Ltd.
Website
https://titanbiotechltd.com
Company type
Public
Founded year
1992
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Titan Biotech is a Delhi-headquartered, BSE-listed manufacturer and exporter of biological and specialty chemical products — including collagen peptides, yeast extracts, and peptones — serving nutraceutical, biopharmaceutical, animal nutrition, and food customers across 100+ countries.
Ownership category
akta.pro rank

Titan Biotech industry classification

Industry
Product category
Biological Ingredients Manufacturing
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Food Manufacturing (311), Animal Food Manufacturing (3111)
SIC
Food And Kindred Products (2000), Chemicals & Allied Products (2800), Biological Products, (No Disgnostic Substances) (2836)
akta.pro primary industry
Protein Hydrolysates & Peptides (Enzymatic Hydrolysates, Bioactive Peptides) (AFAJAHAI)
akta.pro secondary industries
Animal-Derived Protein Ingredients (Egg, Collagen/Gelatin, Blood/Plasma Proteins) (AFAJAHAB), Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine) (AFAJAKAG), Gelatin & Animal-Derived Hydrocolloids (Gelatin, Collagen, Isinglass) (AFAJAMAG), Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids) (CRADAOAJ)

Keywords

  • Biological ingredients manufacturing
  • Collagen peptides supplier
  • Yeast extract production
  • Protein hydrolysates manufacturer
  • Biochemical export India

Where Titan Biotech is headquartered

Location

Headquarters

HQ city
Delhi
HQ country
India
HQ region
Asia

Offices3 records

Markets served

Titan Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. B2B Biological Ingredients Manufacturing: Manufacture and export of raw material ingredients for nutraceuticals, pharmaceuticals, cosmeceuticals, and food & beverage industries. Products include collagen peptides, protein hydrolysates, yeast extract, peptone, and specialty ingredients sold in bulk to manufacturers worldwide.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Titan Biotech product offering

Product offering

Core offering

Titan Biotech manufactures and exports biological and biochemical products including collagen peptides, protein hydrolysates, yeast extract, peptone, and calcium propionate. These specialty ingredients are supplied in bulk to manufacturers in the pharmaceutical, nutraceutical, cosmeceutical, food & beverage, and animal nutrition industries across more than 100 countries.

Product overview

Titan Biotech Limited is a manufacturer and exporter of biological products serving the pharmaceutical, nutraceuticals, food, and animal nutrition industries. The company's product portfolio centers on protein-based ingredients including collagen peptides (bovine, fish, and chicken-derived), various protein supplements (whey, milk, pea, brown rice, soy), and specialty ingredients like yeast extract, peptone, and protein hydrolysates. Their offerings span branded finished products (OXIBIL® ox bile extract, Titagen® fish collagen, Unstergen® chicken collagen) and bulk raw material ingredients. The company also produces animal nutrition additives including calcium propionate, active dry yeast, mannan oligosaccharides, chelated minerals, and butyrate salts. Supporting the pharmaceutical and nutraceutical segments are products like chondroitin sulfate, hyaluronic acid, L-glutathione, and cow colostrum powder. Manufacturing facilities are GMP and ISO certified, with products distributed across 100+ countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • OXIBIL: Ox Bile Extract Powder brand for digestive health supplements in humans and animals
  • Titagen
  • Unstergen
  • NUTRIVET-CAP
  • Glymagna
  • Collatide
  • Peptech Biosciences
  • TM Media

Products and services

  • Collagen Peptides

Quantifiable outcome

  • 47.62% YoY revenue growth to ₹56.51 crore in Q3 FY26
  • +2 more outcomes

Companies that use Titan Biotech

Customer profile

Segments5 records

Ideal customer profiles1 record

Titan Biotech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Titan Biotech partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Titan Biotech competitors and assessment

Company assessment

Direct peers

  • Glanbia Nutritionals: Glanbia produces whey protein, milk protein, and other dairy-derived functional ingredients for sports nutrition and food — comparable to Titan's whey, milk protein, and protein hydrolysate lines sold into nutraceutical customers.
  • Rousselot (Darling Ingredients): Rousselot, owned by Darling Ingredients, produces gelatin, collagen peptides, and peptone for pharma, food, and nutrition — a near-perfect comparable on Titan's core collagen and peptone lines, though at significantly larger scale.
  • Ohly (ABF Ingredients): Ohly, part of Associated British Foods, produces yeast extracts, savory flavor bases, and nutritional ingredients for food and fermentation — a direct comparable on Titan's yeast extract powder product line.
  • Gelita: Gelita is the world's leading manufacturer of collagen peptides and gelatin for food, nutraceutical, and pharma applications — directly comparable to Titan's Titagen and Unstergen collagen offerings with overlapping customers and similar hydrolysis technology.
  • Armor Proteines: Armor Proteines manufactures protein hydrolysates, dairy proteins, and collagen peptides for nutrition, sports, and clinical applications — directly comparable to Titan's protein hydrolysate and collagen peptide lines.
  • Bioiberica: Bioiberica produces chondroitin sulfate, hyaluronic acid, collagen, and other animal-derived bioactive ingredients for joint health and pharma — directly comparable to Titan's pharma/nutra ingredients portfolio including chondroitin and HA.
  • Tessenderlo Group (PB Leiner): Through its PB Leiner division, Tessenderlo produces gelatin, collagen hydrolysates, and proteins for food and pharma — directly comparable to Titan's bovine/porcine collagen peptide range.
  • Weishardt Group: Weishardt is a European specialist in gelatin and collagen peptides for nutraceutical, cosmeceutical, and food applications, with comparable source-agnostic (fish/bovine/porcine) manufacturing capability to Titan's collagen business.

Broad incumbents

  • Symrise Diana Pet Food: Symrise's Diana Pet Food division produces palatability enhancers, yeasts, and proteins for pet and animal nutrition — comparable to Titan's animal nutrition ingredients (yeast, MOS, calcium propionate) and peptone portfolio.
  • Kerry Group: Kerry is a global taste and nutrition platform with food ingredients including yeast extracts, hydrolysates, and proteins — overlaps with Titan's yeast extract and HVP food ingredient lines but at much broader portfolio scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Titan Biotech social profiles

Digital presence

Titan Biotech compliance and trust

Trust signal

Compliance8 records

Titan Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Titan Biotech leadership team

Management profile

Number of profiles

Profiles3 records

Titan Biotech subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Titan Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Titan Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Titan Biotech

What does Titan Biotech do?

Titan Biotech manufactures and exports biological and biochemical products including collagen peptides, protein hydrolysates, yeast extract, peptone, and calcium propionate. These specialty ingredients are supplied in bulk to manufacturers in the pharmaceutical, nutraceutical, cosmeceutical, food & beverage, and animal nutrition industries across more than 100 countries.

Is Titan Biotech a public or private company?

Titan Biotech is a public company. It is classified as public and is currently operating.

When was Titan Biotech founded?

Titan Biotech was founded in 1992. It employs 501 to 1,000 people.

Where is Titan Biotech based?

Titan Biotech is headquartered in Delhi, India, in the Asia region.

How does Titan Biotech make money?

One revenue line is on record: B2B Biological Ingredients Manufacturing.

Who are Titan Biotech's main competitors?

Direct peers on record are Glanbia Nutritionals, Rousselot (Darling Ingredients), Ohly (ABF Ingredients), Gelita, Armor Proteines, Bioiberica, Tessenderlo Group (PB Leiner) and Weishardt Group. Broad incumbents are Symrise Diana Pet Food and Kerry Group.

Does Titan Biotech have an API?

No public API is recorded for Titan Biotech.

What industry is Titan Biotech in?

Titan Biotech's product category is Biological Ingredients Manufacturing. Its primary akta.pro industry code is AFAJAHAI, Protein Hydrolysates & Peptides (Enzymatic Hydrolysates, Bioactive Peptides), with a secondary code of AFAJAHAB, Animal-Derived Protein Ingredients (Egg, Collagen/Gelatin, Blood/Plasma Proteins). Its NAICS code is 325414 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ScanXTitan Biotech fixes Oct 23 record date for 1:4 bonus share issueTitan Biotech fixed October 23, 2026 as the record date for a 1:4 bonus share issue, with 1,03,29,625 shares of ₹2 each to be issued. The deemed allotment date is October 26, 2026, and shares become tradable from October 27, 2026. The proposal received in-principal approval from BSE after shareholder approval at the September 29 AGM.Business StandardTitan Biotech spurts after board approves 1:4 bonus issueTitan Biotech's board approved a 1:4 bonus issue, sending shares up 4.86% to Rs 435. The issue would raise paid-up equity from Rs 8.26 crore to Rs 10.33 crore, with shares expected by November 2026. The company also fixed a final dividend of Rs 0.50 per share.Business StandardTitan Biotech jumps 5% on 1:4 bonus issue, dividend announcementsTitan Biotech shares rose over 5% after announcing a 1:4 bonus issue and a ₹0.50 per-share final dividend for FY26, with the record date set for September 22. The stock has surged 208% over the past year and 536% in five years. A broker advised avoiding the stock due to low liquidity.ScanXTitan Biotech sets Sep 29 for 34th AGM and final dividend record dateTitan Biotech scheduled its 34th AGM for September 29, 2026, with a record date of September 22, 2026 for the final dividend. The board recommended a ₹0.50 per share dividend, pending shareholder approval at the AGM.The Times of IndiaBonus issue alert! Multibagger Titan Biotech announces its maiden 1:4 bonus issueTitan Biotech's board approved a 1:4 bonus issue, increasing authorized capital from Rs 10 crore to Rs 10.4 crore. The company will use nearly Rs 2.07 crore from reserves, and shares rose 5% to Rs 435.55 on BSE. The record date for eligibility has not been announced.ScanXStocks to Watch Today, September 1, 2026: Cipla, Titan Biotech, Indo Tech Transformers, E2E Networks and Time TechnoplastOn September 1, 2026, E2E Networks secured a ₹1,000 crore NVIDIA Blackwell GPU order, while Milky Mist Dairy reported an 890% profit surge in Q1FY27. Cipla signed an exclusive licensing deal for HER2 ADC TQB2102 with SBP Group, and Time Technoplast posted 20.8% PAT growth. The day's focus was on AI infrastructure capex and consumer staples earnings.SahiTitan Biotech Board To Consider Bonus Share Issue On September 3Titan Biotech's board will meet on September 3, 2026, to consider a bonus share issue and finalize AGM details. The company reported Q1 FY27 net profit of ₹10.86 crore, up 58.31% year-on-year, and sales of ₹59.17 crore, up 27.25%. Insider trading restrictions are in place from August 31.Business StandardTitan Biotech consolidated net profit rises 58.31% in the June 2026 quarterTitan Biotech reported a 58.31% increase in consolidated net profit to Rs 10.86 crore for the quarter ended June 2026, compared to Rs 6.86 crore in the same period of the previous year. Sales also rose by 27.25% to Rs 59.17 crore during this period.ScanXTitan Biotech closes trading window from July 1 for Q1FY26 resultsTitan Biotech Ltd has closed its trading window effective July 1, 2026, prohibiting insiders from trading in company securities until 48 hours after the announcement of Q1FY26 results. The company stated it is adhering to SEBI regulations on insider trading prevention. The board meeting date for the June 2026 quarter results has not yet been scheduled.GlobeNewswireZinc Methionine Chelates Market Forecast Report 2025-2033 Featuring Alltech, Balchem, Titan Biotech, UNO VETCHEM, Zinpro, Chaitanya Biologicals, Chengdu Chelation Biology, JH, Novus, PriyaResearchAndMarkets.com published a market forecast report projecting the Zinc Methionine Chelates market to grow from US$15.64 million in 2025 to US$26.51 million by 2033, representing a compound annual growth rate of 6.82%.